Abevmy 100 mg Injection
  1. Home
  2. Pharma Products
  3. Mylan Pharmaceuticals Pvt Ltd
  4. Abevmy 100 mg Injection

Abevmy 100 mg Injection

Abevmy 100 mg Injection contains bevacizumab 100 mg, a monoclonal antibody used as targeted cancer therapy. It is used for cancers including colorectal, non-small-cell lung, kidney, ovarian, cervical, and certain other cancers. The medicine is administered by intravenous infusion by a healthcare professional under medical supervision.

BUY NOW

Category

Bevacizumab works by blocking vascular endothelial growth factor (VEGF), which helps reduce the formation of blood vessels that supply tumors. It is commonly used with other anticancer medicines according to the cancer type and prescribed treatment protocol. Blood pressure, urine protein, bleeding, and wound healing may require monitoring during treatment. The dosage and treatment schedule are individualized by the treating oncologist according to the patient’s condition and response to therapy.

Technical Specification

Specification Details
Active Ingredient Bevacizumab
Strength 100 mg
Concentration 25 mg/mL
Dosage Form Solution for Infusion
Route of Administration Intravenous Infusion
Pack Size 1 Vial, 4 mL

Product Also Known As

Abevmy 100 mg Injection, Abevmy 100mg Injection, Abevmy 100 mg Vial, Abevmy 100mg Vial, Bevacizumab 100 mg Injection, Bevacizumab 100mg Injection, Bevacizumab 100 mg Vial